US Stock MarketDetailed Quotes

ConMed (CNMD)

Watchlist
  • 49.320
  • -0.100-0.20%
Close Sep 4 16:00 ET
  • 49.320
  • 0.0000.00%
Post 19:30 ET
1.48BMarket Cap26.66P/E (TTM)

About ConMed Company

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Company Profile

SymbolCNMD
Company NameConMed
Listing DateFeb 10, 2020
ISINUS2074101013
Founded1970
CEOMr. Patrick J. Beyer
MarketNYSE
Employees3900
Fiscal Year Ends12-31
Address11311 Concept Boulevard
CityLargo
ProvinceFlorida
CountryUnited States of America
Zip Code33773
Phone1-727-392-6464
Websitehttp://www.conmed.com

Company Executives

  • Name
  • Position
  • Salary
  • Patrick J. Beyer
  • Director, President and Chief Executive Officer
  • 7.63M
  • Richard Glaze
  • Chief Information Officer
  • --
  • Matthew Schabacker
  • Vice President and General Manager, U.S. Advanced Surgical
  • --
  • Andrew James Moller
  • Vice President and Principal Accounting Officer
  • --
  • Johonna Pelletier
  • Treasurer and Vice President, Tax
  • --
  • Hollie K. Foust
  • Executive Vice President, General Counsel and Corporate Secretary
  • 1.84M
  • Peter K. Shagory
  • Executive Vice President, Strategy and Corporate Development
  • 1.56M
  • John D. Ferrell
  • Executive Vice President, Human Resources
  • --
  • Brent Lalomia
  • Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, Commercial Operations, and IT
  • 1.66M
  • LaVerne H. Council
  • Chairman of the Board
  • 308.00K
  • Barbara J. Schwarzentraub
  • Independent Director
  • 290.36K
  • Mark B. Kaye
  • Independent Director
  • 310.73K
  • Kim Kelderman
  • Independent Director
  • 161.72K
  • David M. Bronson
  • Independent Director
  • 282.13K
  • Charles M. Farkas
  • Independent Director
  • 278.75K
  • Brian P. Concannon
  • Independent Director
  • 279.99K
  • Celine Christine Martin
  • Independent Director
  • --
  • Jeff Mirviss
  • Independent Director
  • --
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +27.84%
Sample Name
Sample Code
 +23.21%
Sample Name
Sample Code
 +20.33%
4
United Sts Brent Oil Fd Lp Unit
BNO
+19.56%
5
United States Gasoline Fund Lp
UGA
+19.32%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +8.44%
Sample Name
Sample Code
 +8.25%
Sample Name
Sample Code
 +7.96%
4
United Microelectronics
UMC
+4.95%
5
TAL Education
TAL
+3.85%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -